Mar 20 Finding a way to avoid genetic discrimination

2018-03-31

With genomic profiling technology, more subsets of patients with common cancers are found harboring cancer-predisposing germline genetic alterations. Certain breast, ovary, pancreas, prostate and melanoma cancer patients carry hereditary BRCA1/2 mutations; certain stomach, colon, breast cancer patients carry hereditary CDH1 mutations; while certain GI, ovary, pancreas, urothelial and brain cancer patients carry hereditary MMR mutations. The Precision Oncology-Protection from Genetic Discrimination Symposium in Hong Kong attracted more than 145 oncology professionals. Dr. Shu-Jen Chen, Chief Scientific Officer of ACT Genomics joined oncologists to explore detection of germline mutations with NGS, share cases of early cancer treatment, and discuss how to assist patients with hereditary genetic mutations to avoid genetic discrimination.

Image title